Kolexia
Dufresne Armelle Oncologie médicale
Dufresne Armelle
Oncologie médicale
Centre Léon-Bérard
Lyon, France
171 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Tumeurs des tissus mous Tumeurs du sein Fibromatose agressive Tumeurs stromales gastro-intestinales Récidive tumorale locale Fibrome Métastase tumorale Tumeurs osseuses

Collaborateurs

Voir plus
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France
Brahmi Mehdi
Brahmi Mehdi
Centre Léon-Bérard, Lyon, France
Le Cesne Axel
Le Cesne Axel
Gustave-Roussy, Villejuif, France
Ray Isabelle
Ray Isabelle
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
Pharma Mar
3 collaboration(s)
Dernière en 2023
Ipsen
1 collaboration(s)
Dernière en 2023
MSD
1 collaboration(s)
Dernière en 2022
Lilly
1 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
CHIC-STS01: Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   26 février 2024
COTESARC: A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Essai Clinique (Centre Léon-Bérard)   09 février 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
ePPS-2202: Phase 3 Superiority Trial Evaluating the Benefit of Dematerialized Information Media for Patients With Advanced Sarcomas Receiving Second Line Treatment.
Essai Clinique (Centre Oscar-Lambret)   24 janvier 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
European journal of cancer (Oxford, England : 1990)   23 novembre 2023
EMPIRE: Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures
Essai Clinique (Boehringer Ingelheim)   19 octobre 2023
1921MO Patterns of care, outcome and molecular landscape of PATZ1-rearranged sarcomas identifies two prognostic profiles: A cohort study from the French Sarcoma Group (FSG)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1975P Systemic therapy for KIT/PDGFRA wild-type GIST
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023